LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS

Their core work

The Lithuanian University of Health Sciences (LSMU) is Lithuania's leading medical university based in Kaunas, combining clinical medicine, veterinary sciences, and public health research. In H2020, they contributed expertise in vaccine effectiveness monitoring, human biomonitoring of chemical exposures, proton beam therapy research, and sustainable animal production. Their work spans from population-level health surveillance (COVID-19 and influenza networks) to patient-centred mental health care and ruminant microbiome research, reflecting their dual medical-veterinary identity.

What they specialise in

How they've shifted over time

LSMU's early H2020 work (2015-2018) centred on sustainable animal production, healthy ageing capacity building, and vaccine monitoring — reflecting their agricultural-veterinary and public health roots. From 2018 onward, they shifted toward environmental health (human biomonitoring, chemical exposure), advanced radiation therapy, and patient-centred mental health care. The trend shows a move from traditional agricultural and infectious disease work toward more interdisciplinary health research addressing chronic conditions and environmental determinants of health.

LSMU is expanding from traditional veterinary-medical research into environmental health determinants and biopsychosocial care models, making them an increasingly relevant partner for projects bridging One Health, mental health, and population health monitoring.

How they like to work

LSMU participates exclusively as a partner or third party — they have not coordinated any H2020 project, which is typical for a mid-sized Baltic university building its European research network. With 264 unique partners across 38 countries, they plug into very large consortia (HBM4EU, I-MOVE networks) rather than leading small focused teams. This means they bring reliable domain expertise without the overhead of project management, making them a low-risk addition to large-scale collaborative proposals.

LSMU has built a remarkably broad network of 264 partners across 38 countries — impressive for a university with only 9 projects, achieved by joining large pan-European consortia. Their reach is genuinely continental with no narrow geographic clustering.

What sets them apart

LSMU's combined medical and veterinary university structure gives them a genuine One Health perspective that few partners can match — they work credibly on both human biomonitoring and ruminant microbiomes. As one of the Baltic states' strongest health sciences institutions, they also provide geographic coverage that many Western European consortia need for Widening Participation criteria. Their track record in large epidemiological networks (I-MOVE, HBM4EU) demonstrates they can deliver reliable data collection across populations that are underrepresented in EU-wide studies.

Highlights from their portfolio

• HBM4EU
  The flagship European Human Biomonitoring Initiative — LSMU's participation (as third party) placed them in one of H2020's most high-profile environmental health projects with direct policy translation impact.
• HoloRuminant
  Their largest single EC contribution (EUR 219,335), focusing on ruminant microbiome research — a rapidly growing field connecting animal health, sustainability, and food production.
• ESCAPE
  Their most recent and longest-running project (2021-2026), representing a new research direction in biopsychosocial mental health care for patients with multiple chronic conditions.